Benefit of Tacrolimus/Myocophenolate To Reduce Cardiac Allograft Vasculopathy after Heart Transplantation

被引:0
|
作者
Patel, J. [1 ]
Kittleson, M. [1 ]
Rafiei, M. [1 ]
Osborne, A. [1 ]
Aaronson, A. [1 ]
Chang, D. H. [1 ]
Azarbal, B. [1 ]
Czer, L. [1 ]
Moriguchi, J. [1 ]
Kobashigawa, J. [1 ]
机构
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
114
引用
收藏
页码:S50 / S50
页数:1
相关论文
共 50 条
  • [21] Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy
    Huibers, M.
    van Pijpen, E.
    Kirkels, H.
    de Jonge, N.
    Vink, A.
    de Weger, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S136 - S136
  • [22] Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantation
    Aziz, T
    Hasleton, P
    Hann, AW
    Yonan, N
    Deiraniya, A
    Hutchinson, IV
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (04): : 700 - 707
  • [23] Uric Acid is an Independent Predictor of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Prasad, Megha
    Briasoulis, Alexandros
    Boilson, Barry A.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Pereira, Naveen L.
    Adigun, Rosalyn
    Simon, Maltais
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    CIRCULATION, 2017, 136
  • [24] Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation
    Julius, BK
    Jost, CHA
    Sütsch, G
    Brunner, HP
    Kuenzli, A
    Vogt, PR
    Turina, M
    Hess, OM
    Kiowski, W
    TRANSPLANTATION, 2000, 69 (05) : 847 - 853
  • [25] Validation of the Cardiac Allograft Vasculopathy (CAV) Trajectory Score after Heart Transplantation
    Patel, N.
    Kittleson, M.
    Chang, D.
    Patel, J.
    Azarbal, B.
    Singer-Englar, T.
    Geft, D.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S205 - S205
  • [26] Expression of iNOSmRNA to prevent cardiac allograft vasculopathy after heart transplantation in rat
    吴乃石
    藏旺福
    张科峰
    张明宇
    姚志发
    ChinaMedicalAbstracts, 2005, (04) : 293 - 296
  • [27] Identification and Determinants of Cardiac Allograft Vasculopathy Trajectories after Heart Transplantation.
    Bonnet, G.
    Coutance, G.
    Racape, M.
    Raynaud, M.
    Van Keer, J.
    Bories, M.
    Varnous, S.
    Rouvier, P.
    Guillemain, R.
    Lecuyer, L.
    Bruneval, P.
    Duong-Van-Huyen, J.
    Taupin, J.
    Naesens, M.
    Lefaucheur, C.
    Jouven, X.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 352 - 353
  • [28] Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation
    Asleh, R.
    Briasoulis, A.
    Smith, B.
    Lopez, C.
    Lerman, A.
    Pereira, N. L.
    Daly, R. C.
    Kremers, W. K.
    Clavell, A. L.
    Stulak, J. M.
    Kushwaha, S. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S76 - S76
  • [29] Uric acid is an independent predictor of cardiac allograft vasculopathy after heart transplantation
    Asleh, Rabea
    Prasad, Megha
    Briasoulis, Alexandros
    Nardi, Valentina
    Adigun, Rosalyn
    Edwards, Brooks S.
    Pereira, Naveen L.
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (09): : 1083 - 1092
  • [30] Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: A histopathological study
    Huibers, Manon M. H.
    Vink, Aryan
    Kaldeway, Johannes
    Huisman, Andre
    Timmermans, Kim
    Leenders, Max
    Schipper, Marguerite E. I.
    Lahpor, Jaap R.
    Kirkels, Hans J. H.
    Klopping, Corinne
    de Jonge, Nicolaas
    de Weger, Roel A.
    ATHEROSCLEROSIS, 2014, 236 (02) : 353 - 359